`
`IN THE UNITED STATES DISTRICT COURT
`
`FOR THE DISTRICT OF DELAWARE
`
`
`
`
`
`IN RE COPAXONE 40 MG CONSOLIDATED
`CASES
`
`
`)
`)
`)
`)
`)
`)
`)
`)
`
`C.A. No. 14-1171-GMS
`
`(CONSOLIDATED)
`
`
`
`NOTICE OF APPEAL
`
`Notice is hereby given that Plaintiffs Teva Pharmaceuticals USA, Inc., Teva
`
`Pharmaceutical Industries, Ltd., Teva Neuroscience, Inc. and Yeda Research and Development
`
`Co. Ltd. hereby appeal to the United States Court of Appeals for the Federal Circuit from the
`
`Final Judgment entered in the above-captioned consolidated actions on January 31, 2017 (Docket
`
`Entry No. 299), including all interlocutory decisions and orders subsidiary thereto and subsumed
`
`therein and all adverse orders, decisions and opinions of the Court in this matter, including the
`
`Order (Docket Entry No. 295) and Memorandum (Docket Entry No. 294) entered on January 30,
`
`2017.
`
`Included herewith is payment of the filing fee ($5.00) and the docketing fee ($500.00) as
`
`required by 28 U.S.C. § 1917, Federal Circuit Rule 52(a)(3)(A), Federal Rule of Appellate
`
`Procedure 3(e), and the United States District Court for the District of Delaware fee schedule
`
`(effective December 1, 2013).
`
`
`
`
`
`
`
`
`
`
`Case 1:14-cv-01171-GMS Document 306 Filed 02/02/17 Page 2 of 2 PageID #: 9404
`
`
`
`OF COUNSEL:
`David M. Hashmall
`Elizabeth J. Holland
`GOODWIN PROCTER LLP
`The New York Times Building
`620 Eighth Avenue
`New York, NY 10018-1405
`(212) 813-8800
`
`Paul F. Ware
`Daryl L. Wiesen
`John T. Bennett
`Nicholas K. Mitrokostas
`GOODWIN PROCTER LLP
`100 Northern Ave.
`Boston, MA 02110
`(617) 570-1000
`
`William G. James
`GOODWIN PROCTER LLP
`901 New York Avenue, NW
`Washington, DC 20001
`(202) 346-4000
`
`
`Dated: February 2, 2017
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`/s/ Karen E. Keller
`John W. Shaw (No. 3362)
`Karen E. Keller (No. 4489)
`David M. Fry (No. 5486)
`SHAW KELLER LLP
`300 Delaware Avenue, Suite 1120
`Wilmington, DE 19801
`(302) 298-0700
`jshaw@shawkeller.com
`kkeller@shawkeller.com
`dfry@shawkeller.com
`
`Richard D. Kirk (No. 922)
`Stephen B. Brauerman (No. 4952)
`BARYARD, P.A.
`222 Delaware Avenue, Suite 900
`Wilmington, DE 19801
`(302) 655-5000
`rkirk@bayardlaw.com
`sbrauerman@bayardlaw.com
`
`Attorneys for Plaintiffs Teva
`Pharmaceuticals USA, Inc., Teva
`Pharmaceutical Industries, Ltd., Teva
`Neuroscience, Inc. and Yeda Research
`& Development Co.
`
`
`2
`
`